N4 Pharma PLC (N4P) - Total Liabilities

Latest as of June 2025: GBX78.37K GBX ≈ $9.53 USD

Based on the latest financial reports, N4 Pharma PLC (N4P) has total liabilities worth GBX78.37K GBX (≈ $9.53 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore N4 Pharma PLC (N4P) cash conversion ratio to assess how effectively this company generates cash.

N4 Pharma PLC - Total Liabilities Trend (1985–2024)

This chart illustrates how N4 Pharma PLC's total liabilities have evolved over time, based on quarterly financial data. Check N4 Pharma PLC asset resilience ratio to evaluate the company's liquid asset resilience ratio.

N4 Pharma PLC Competitors by Total Liabilities

The table below lists competitors of N4 Pharma PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Tiger Royalties and investments Plc LSE:TIR	UK	GBX91.36K
Coro Energy PLC LSE:CORO	UK	GBX2.59 Million
Catenai PLC LSE:CTAI	UK	GBX253.69K
Norman Broadbent Plc LSE:NBB	UK	GBX2.98 Million
Bangkok Bank Public Company Limited F:BKKF	Germany	€4.03 Trillion
Fitness Champs Holdings Limited Common Stock NASDAQ:FCHL	USA	$2.35 Million
Novae Group Plc STU:NVAL	Germany	€414.37 Billion

Liability Composition Analysis (1985–2024)

This chart breaks down N4 Pharma PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see N4 Pharma PLC market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	23.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how N4 Pharma PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for N4 Pharma PLC (1985–2024)

The table below shows the annual total liabilities of N4 Pharma PLC from 1985 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX124.37K ≈ $15.13	+52.18%
2023-12-31	GBX81.73K ≈ $9.94	+4.93%
2022-12-31	GBX77.89K ≈ $9.48	-63.39%
2021-12-31	GBX212.73K ≈ $25.88	+25.81%
2020-12-31	GBX169.08K ≈ $20.57	+117.66%
2019-12-31	GBX77.68K ≈ $9.45	-59.14%
2018-12-31	GBX190.12K ≈ $23.13	+6.08%
2017-12-31	GBX179.22K ≈ $21.81	+132.75%
2016-12-31	GBX77.00K ≈ $9.37	+352.94%
2015-12-31	GBX17.00K ≈ $2.07	-97.89%
2014-12-31	GBX807.00K ≈ $98.19	-10.53%
2013-12-31	GBX902.00K ≈ $109.75	-27.43%
2012-12-31	GBX1.24 Million ≈ $151.24	-15.21%
2011-12-31	GBX1.47 Million ≈ $178.37	+41.51%
2010-12-31	GBX1.04 Million ≈ $126.05	-10.69%
2009-12-31	GBX1.16 Million ≈ $141.14	+109.39%
2008-12-31	GBX554.00K ≈ $67.41	+4.53%
2007-12-31	GBX530.00K ≈ $64.49	+4.13%
2006-12-31	GBX509.00K ≈ $61.93	-86.84%
2005-12-31	GBX3.87 Million ≈ $470.75	-4.89%
2004-12-31	GBX4.07 Million ≈ $494.96	-13.72%
2003-12-31	GBX4.71 Million ≈ $573.68	-2.82%
2002-12-31	GBX4.85 Million ≈ $590.35	-6.84%
2001-12-31	GBX5.21 Million ≈ $633.66	-35.17%
2000-12-31	GBX8.03 Million ≈ $977.38	-8.04%
1999-12-31	GBX8.73 Million ≈ $1.06K	-13.52%
1998-12-31	GBX10.10 Million ≈ $1.23K	-61.40%
1997-12-31	GBX26.17 Million ≈ $3.18K	+11.12%
1996-12-31	GBX23.55 Million ≈ $2.87K	-6.58%
1995-12-31	GBX25.21 Million ≈ $3.07K	+33.58%
1994-12-31	GBX18.88 Million ≈ $2.30K	+55.53%
1993-12-31	GBX12.14 Million ≈ $1.48K	-33.39%
1992-12-31	GBX18.22 Million ≈ $2.22K	-9.15%
1991-12-31	GBX20.05 Million ≈ $2.44K	+223.44%
1990-12-31	GBX6.20 Million ≈ $754.36	-13.95%
1989-12-31	GBX7.21 Million ≈ $876.64	+0.63%
1988-12-31	GBX7.16 Million ≈ $871.16	+17.11%
1987-12-31	GBX6.11 Million ≈ $743.90	+30.17%
1986-12-31	GBX4.70 Million ≈ $571.49	-15.96%
1985-12-31	GBX5.59 Million ≈ $680.02	--

About N4 Pharma PLC

LSE:N4P UK Drug Manufacturers - Specialty & Generic

Market Cap

$48.10K

GBX395.33 Million GBX

Market Cap Rank

#31125 Global

#1204 in UK

Share Price

GBX0.48

Change (1 day)

+0.00%

52-Week Range

GBX0.38 - GBX0.73

All Time High

GBX32.90